Advisors Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,822
| Closed | -$292K | – | 1506 |
|
|
2022
Q3 | $292K | Sell |
5,822
-341
| -6% | -$17.1K | 0.01% | 1064 |
|
|
2022
Q2 | $247K | Sell |
6,163
-3,084
| -33% | -$124K | ﹤0.01% | 1115 |
|
|
2022
Q1 | $345K | Sell |
9,247
-1,338
| -13% | -$49.9K | 0.01% | 1107 |
|
|
2021
Q4 | $422K | Sell |
10,585
-285
| -3% | -$11.4K | 0.01% | 1052 |
|
|
2021
Q3 | $404K | Buy |
10,870
+10
| +0.1% | +$372 | 0.01% | 1075 |
|
|
2021
Q2 | $459K | Buy |
10,860
+156
| +1% | +$6.59K | 0.01% | 1031 |
|
|
2021
Q1 | $507K | Buy |
10,704
+2,298
| +27% | +$109K | 0.01% | 1012 |
|
|
2020
Q4 | $513K | Buy |
8,406
+5,017
| +148% | +$306K | 0.01% | 958 |
|
|
2020
Q3 | $158K | Buy |
3,389
+1,570
| +86% | +$73.2K | ﹤0.01% | 1231 |
|
|
2020
Q2 | $92K | Buy |
+1,819
| New | +$92K | ﹤0.01% | 1318 |
|